關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

搜尋結果Search Result

符合「EP100」新聞搜尋結果, 共 11 篇 ,以下為 1 - 11 篇 訂閱此列表,掌握最新動態
ACE Biotek and Shin Kong Wu Ho-Su Memorial Hospital to Showcase Spark Surgical Anesthesia System and EP100 Ophthalmology Recording System at Healthcare Expo Taiwan

Hsinchu, Taiwan, November 7, 2024 – ACE Biotek is at the forefront of smart hospital development in Taiwan, focusing on digital integration systems for ophthalmology, anesthesia, and electronic medical records. These advanced healthcare solutions have been successfully implemented at Shin Kong Wu Ho-Su Memorial Hospital and other leading healthcare institutions across Taiwan, receiving widespread acclaim. ACE Biotek has been invited to exhibit its solutions at the 2024 Healthcare Expo Taiwan from December 5 to December 8. We warmly invite industry professionals to visit our booth and experience the technology firsthand. Don't miss this opportunity to witness the future of healthcare!   The EP100 Ophthalmology Recording System (EaglePark100) can connect with ophthalmic examination equipment, allowing patient data and examination results to be directly displayed on tablet devices, eliminating the need for thermal paper printing and achieving structured data management and a paperless workflow. It supports real-time data transfer among multiple roles, including attending physicians, assistant doctors, nurses, and examination rooms, enhancing clinical efficiency. The user-friendly interface also enables physicians to hand-draw diagnostic illustrations.   The Spark Surgical Anesthesia System digitally integrates data processing for pre-, intra-, and post-operative care across nursing and anesthesia departments, supporting medication management and surgical protocols. It achieves a "real-time and comprehensive collection of physiological monitor and anesthesia machine data." Leveraging medical AI and big data analysis, the system can seamlessly connect with hospital HIS, surgical, and billing systems, significantly enhancing operational efficiency and accuracy by recording real-time anesthesia events and medical interventions.   Exhibition Highlights: 🏥 Spark Surgical Anesthesia System 📝 EP100 Ophthalmology Recording System (EaglePark100) 💡 DS Data Integration System   Exhibition Information: 🌟Location: TaiNEX Hall 1, Booth J118 @ Shin Kong Wu Ho-Su Memorial Hospital   ACE Biotek is seeking collaboration with hospitals and international system integrators (SIs). We welcome healthcare institutions and SI partners from around the world to visit and discuss potential technical and business partnerships.   👉🏻 Booth Tour spots are limited and will be arranged based on availability, so please register early: https://docs.google.com/forms/d/e/1FAIpQLSci4DL2BZeePk-xAcF-wSOk6284zsjLEA7pzCdBC3InGQqfPA/viewform   Contact: Jenny Lin (Marketing Assistant Manager) jenny_lin@acebiotek.com +886-3-5500909#3407/ +886-922168765   About ACE Biotek Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.   Contact ACE Biotek Advanced ACE Biotek Co., Ltd. Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park) Phone: +886-3-5500909 E-mail: service@acebiotek.com Website: https://www.acebiotek.com/ Facebook: https://www.facebook.com/Acebiotek/ LinkedIn: https://www.linkedin.com/company/30620922/admin/

文章來源 : 筑波醫電股份有限公司 發表時間 : 瀏覽次數 : 629 加入收藏 :
ACE Biotek Joins Shin Kong Wu Ho-Su Memorial Hospital to Showcase Smart Ophthalmology and Anesthesia Healthcare Solutions at Taiwan Healthcare Expo

Hsinchu, Taiwan, December 5, 2024 – ACE Biotek, in collaboration with Shin Kong Wu Ho-Su Memorial Hospital, proudly at the 2024 Taiwan Healthcare Expo. Under the theme “Generative AI Driving Medical Innovation, ESG Leading the Future of Health,” the event highlighted achievements in intelligent healthcare and sustainable development. Since signing an MOU in 2023, the partnership has focused on developing and applying the Spark Surgical Anesthesia System and the EP100 Ophthalmology Recording System (EaglePark100). Interactive on-site demonstrations attracted numerous medical professionals.   The opening day featured key leadership figures from Shin Kong Wu Ho-Su Memorial Hospital, including Chairman Eugene Wu, Superintendent Sheng-Mao Hou, and Vice Superintendent Tzu-Jen Hung, engaging with attendees. Dr. Nina Kao, Executive Director of Changhua Christian Hospital's Overseas Medical Mission Center, led a delegation of 30 hospital representatives from Thailand and Papua New Guinea to visit the booth, highlighting the global interest in intelligent medical technologies and showcasing the widespread acclaim for ACE Biotek's innovations.   ACE Biotek presented two flagship solutions, the EP100 Ophthalmology Recording System (EaglePark100) and the Spark Surgical Anesthesia System. The EP100 focuses on data sharing and collaboration, seamlessly integrating examination rooms with clinics. It enables digitized, structured, and paperless data management, significantly enhancing medical efficiency and precision and benefiting physicians, nurses, and technicians alike. Meanwhile, the Spark Surgical Anesthesia System integrates anesthesia data throughout surgical processes, from physiological monitors to anesthesia machines, ensuring real-time data recording and seamless data flow. It can flexibly integrate with hospital HIS, surgery, and pricing systems while leveraging AI-powered medical big data to improve operational efficiency and accuracy, helping hospitals achieve smarter, standardized surgical management.   Steve Hsu, President of ACE Biotek, remarked: "We are honored to collaborate with Shin Kong Wu Ho-Su Memorial Hospital, supporting their ESG sustainability goals with innovative smart healthcare solutions. This exhibition showcases ACE Biotek's leadership in advanced medical technologies and our commitment to fostering partnerships to advance the globalization of smart healthcare."   Shin Kong Wu Ho-Su Memorial Hospital remains committed to ESG principles, reducing carbon emissions and setting a benchmark for sustainability within the healthcare industry. By collaborating with ACE Biotek, the hospital is advancing its digital transformation towards a comprehensive smart hospital framework. ACE Biotek will continue innovating and developing cutting-edge smart medical solutions, fostering partnerships to elevate the next generation of healthcare and contributing to the development of green, sustainable smart hospitals.   About ACE Biotek Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.   Contact ACE Biotek Advanced ACE Biotek Co., Ltd.Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)Phone: +886-3-5500909E-mail: service@acebiotek.comWebsite: https://www.acebiotek.com/Facebook: https://www.facebook.com/Acebiotek/LinkedIn: https://www.linkedin.com/company/30620922/admin/  

文章來源 : 筑波醫電股份有限公司 發表時間 : 瀏覽次數 : 241 加入收藏 :
筑波醫電攜手新光醫院,共展眼科與麻醉智慧醫療方案—聚焦創新與永續,亮相台灣醫療科技展

台灣新竹,2024年12月5日 – 筑波醫電攜手新光醫院,亮相2024台灣醫療科技展,以「生成式AI建置驅動醫療革新,ESG引領健康未來」為主題,展現智慧醫療與永續發展的實踐成果。自2023年簽訂合作備忘錄MOU以來,雙方積極推動Spark手術麻醉系統及EP100眼科數位紀錄系統開發與應用。本次展會設有現場互動體驗,吸引眾多醫界專業人士駐足。   展覽首日,新光醫院董事長吳東進、院長侯勝茂及副院長洪子仁等領導出席開幕儀式,並與現場嘉賓深入交流。此外,彰化基督教醫院海外醫療中心執行長高小玲博士率領來自泰國及巴布亞紐幾內亞的30位醫院代表到場參觀,場面熱烈,展現出國際間智慧醫療技術的廣泛關注與高度肯定。   筑波醫電本次展出兩大焦點,EP100眼科數位紀錄系統以數據共享與診間協作為核心,模擬檢查室與診間的無縫連結。透過電子化技術實現數據結構化與無紙化管理,大幅提升醫療效率與協作精準度,對醫師、護理師及檢查人員皆帶來極大便利。Spark手術麻醉系統則全面整合手術過程的麻醉數據,從生理監視器到麻醉機資料,實現即時記錄與完整數據流轉。系統能靈活整合醫院HIS、手術與批價系統,並結合醫療AI大數據,提升作業效率與準確性,助力醫院實現智慧手術的高效化與標準化管理。   筑波醫電董事長許深福指出:「我們很榮幸與新光醫院攜手合作,針對其ESG永續經營目標,提供創新的智慧醫療解決方案。本次展會充分展現筑波醫電在高端醫材技術的領先優勢,並期待深化國內外合作夥伴關係,共同推動智慧醫療的國際化發展。」   新光醫院持續致力於實踐ESG永續醫療,透過減少碳排放推動永續經營,並成為醫療產業中ESG卓越的典範。與筑波醫電合作推動醫療數位化,朝向全方位智慧醫院的藍圖邁進。筑波醫電將繼續專注於智慧醫材的創新與研發,與各醫療夥伴攜手共創醫療新世代,並提升智慧醫院的綠色永續,為數位醫療發展提供先進方案。   關於筑波醫電ACE Biotek 筑波醫電大樓是董事長許深福先生驅動內心的寄望及理念,依據建築設計師、施工團隊及同仁們很科學的作品。是筑波人多年來文化、創意技術的展現,是筑波全體同仁長久對生醫產業接軌國際平台的堅持。筑波科技集團以豐富的無線通訊軟硬體整合經驗、結合半導體晶片、醫學影像演算法、雲端技術、人工智慧、臨床醫師專業、法規驗證與專利技術綜效,著力於人們早期病變篩檢系統的精準醫療設備產品研發與生產。期望不但可以減少病患及家人的遺憾,並開拓台灣本土精密無創微創醫檢設備能量且推廣於國際,更建立台灣從3C到三醫(醫才、醫技、醫材)的產業鏈轉型平台與人才的培育之目標。 連絡筑波醫電 筑波醫電股份有限公司 Advanced ACE Biotek Co., Ltd.地址:30261新竹縣竹北市生醫二路66號 (新竹生醫園區)電話: +886-3-5500909E-mail: service@acebiotek.com網站: https://www.acebiotek.com/Facebook: https://www.facebook.com/Acebiotek/LinkedIn: https://www.linkedin.com/company/30620922/admin/

文章來源 : 筑波醫電股份有限公司 發表時間 : 瀏覽次數 : 2230 加入收藏 :
筑波醫電攜手新光醫院亮相台灣醫療科技展 展示Spark手術麻醉系統與看得健100眼科數位紀錄系統成果

台灣新竹,2024年11月07日 – 筑波醫電引領我國智慧醫院發展,專注於眼科與麻醉數位化整合系統及電子病歷系統的開發。相關智慧醫療方案已成功應用於新光醫院及多家國內具代表性的醫療機構,廣受好評。筑波醫電受邀參加2024年12月5日至12月8日台灣醫療科技展,將於現場展示方案,誠摯邀請各界人士蒞臨體驗與指教。   看得健100眼科數位紀錄系統 (EP100) 可串接眼科檢查儀器,讓病患資料與檢查數據直接顯示於平板裝置,無需列印感熱紙,實現數據結構化與無紙化管理。此外支持多角色協作如:主治醫師、協作醫師、護理師與檢查室之間的即時資料傳輸,提升看診效率。人性化界面可輔助醫師手繪診斷。   Spark手術麻醉系統則數位化整合護理部與麻醉部在手術前、中、後資料處理,並支援藥物管理與手術模式,實現「即時且完整收集生理監視器與麻醉機資料」。結合醫療AI大數據分析,可靈活對接醫院的HIS、手術系統及批價系統,提升作業效率與準確性,即時記錄麻醉事件與醫護處置。   展出亮點: 🏥 Spark手術麻醉系統 📝 EP100眼科數位紀錄系統 (看得健100) 💡 DS數據上傳整合系統   展覽資訊: 🌟地點:台北南港展覽館一館,攤位:J118 @新光醫院 尋找合作醫院、國際醫療系統整合商 (SI) 合作夥伴,誠邀國內外醫療院所、SI商蒞臨參觀。歡迎各界夥伴蒞臨,討論技術及商業合作 👉🏻 Booth Tour名額有限,將依實際狀況安排,請及早報名:https://docs.google.com/forms/d/e/1FAIpQLSci4DL2BZeePk-xAcF-wSOk6284zsjLEA7pzCdBC3InGQqfPA/viewform Contact: Jenny Lin (Marketing Assistant Manager) jenny_lin@acebiotek.com +886-3-5500909#3407/ +886-922168765 關於筑波醫電ACE Biotek 筑波醫電大樓是董事長許深福先生驅動內心的寄望及理念,依據建築設計師、施工團隊及同仁們很科學的作品。是筑波人多年來文化、創意技術的展現,是筑波全體同仁長久對生醫產業接軌國際平台的堅持。筑波科技集團以豐富的無線通訊軟硬體整合經驗、結合半導體晶片、醫學影像演算法、雲端技術、人工智慧、臨床醫師專業、法規驗證與專利技術綜效,著力於人們早期病變篩檢系統的精準醫療設備產品研發與生產。期望不但可以減少病患及家人的遺憾,並開拓台灣本土精密無創微創醫檢設備能量且推廣於國際,更建立台灣從3C到三醫(醫才、醫技、醫材)的產業鏈轉型平台與人才的培育之目標。 連絡筑波醫電 筑波醫電股份有限公司Advanced ACE Biotek Co., Ltd. 地址:30261新竹縣竹北市生醫二路66號 (新竹生醫園區) 電話: +886-3-5500909 E-mail: service@acebiotek.com 網站: https://www.acebiotek.com/ Facebook: https://www.facebook.com/Acebiotek/ LinkedIn: https://www.linkedin.com/company/30620922/admin/

文章來源 : 筑波醫電股份有限公司 發表時間 : 瀏覽次數 : 2818 加入收藏 :
DFI To Present Latest Innovations Alongside Partner Dynalog at Embedded Tech India Expo 2024

TAIPEI, Jan. 16, 2024 /PRNewswire/ -- DFI, a global leader in embedded motherboards and industrial computers, has announced their participation in the Embedded Tech India Expo for the first time. In collaboration with distribution partner Dynalog, they will be showcasing their range of rugged industrial-grade products, industrial motherboards, and embedded systems. DFI hopes to assist customers and industries in India in achieving their demands for digital transformation and intelligentization. This flagship event is co-located with India's largest tech and infra expo, the Convergence India Expo. Held at Pragati Maidan in New Delhi, India, from January 17th to January 19th, the expo brings together powerful business and technology leaders in the embedded technologies industry to share their knowledge and explore new solutions. DFI's products will be displayed alongside Dynalog's networking solutions at their joint exhibition booth. With over 40 years of legacy, Dynalog India Ltd, is a distinguished leader of automation solutions recognized across India and is one of DFI's most important distributors and partners. DFI will present flagship products such as the ECX700-AL rugged embedded system, EP100-AL compact PC, PCSF51 SBC, and the latest SOM modules for applications in factory automation, transportation, and military industries in India. These products are already being implemented and have achieved positive results in India. For example, DFI has initiated production on an SOM module with wide temperature range for an aerospace and defense electronics company. The customer chose DFI after reviewing more than five industrial PC competitors, because DFI could provide the most comprehensive support and customization services. With India's market potential and DFI's cutting-edge technologies, DFI aspires to become the best partner in India's industrial transformation. DFI supports government initiatives such as the "Make in India" initiative that promotes entrepreneurship and encourages companies to manufacture products made in India. From government to private sectors, DFI is committed toward contributing its services and enabling companies to realize their goals. DFI will continue to seize opportunities in India by delivering its industrial-grade embedded solutions for industrial automation, military defense, smart transportation, smart city, and other sectors while enhancing its presence through participation in local events. Exhibition Dates: 17th -19th January 2024 Venue: Pragati Maidan, New Delhi, India Booth No.: B158 For more information, please visit: LinkedIn or contact us. Media Contact Eva Chen eva.chen@dfi.comEvelyn Chang evelyn.chang@dfi.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 680 加入收藏 :
LONGi Receives Science Based Target initiative (SBTi) Approval for Emission Reduction Targets

XI'AN, China, Aug. 11, 2023 /PRNewswire/ -- LONGi, the world leading solar technology company on August 11, 2023 announced that its emission reduction targets were approved by the independent Science Based Targets initiative (SBTi). With the approval, LONGi has become one of more than 4600 companies worldwide that have joined the SBTi and set science-based targets. Among them, LONGi is the first Chinese solar photovoltaic company that has obtained the official validation.    The SBTi is a partnership between CDP, the United Nations Global Compact (UNGC), World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi call to action is one of the We Mean Business Coalition commitments. It drives ambitious climate action in the private sector by enabling organizations to set science-based emissions reduction targets, highlighting companies' competitiveness and sense of responsibility in terms of sustainable development and ESG.  LONGi officially participated in the SBTi and committed to set a near-term target in 2020. In the next year, the company published 2021 Climate Actions of LONGi outlining its SBTi targets: by 2030, the GHG (greenhouse gas) emissions within the operational boundary is scheduled to reduce by 60% from that of the 2020 level; the carbon emissions of unit silicon material, cell and glass will be reduced by at least 20% compared with that in 2020. This year, LONGi's near-term target has been approved by the SBTi, aligning with the 1.5℃ target in the Paris Agreement. In 2020, LONGi also successively joined initiatives of RE100, EP100, EV100 and participated in the SBTi, becoming the first Chinese company to join the four global initiatives all together. From 2012 to 2022, the company had produced a total of 290GW of photovoltaic products, generating over 114 billion kWh of clean electricity. When calculated using the International Energy Agency (IEA)'s Emission Factors, LONGi had helped prevent 536 million tons of CO₂ emissions, equivalent to 1.46% of 2022's global energy-related carbon emissions. "The approval of SBTi signifies the global recognition of our commitment to addressing climate change and helps us continue the work of comprehensive value chain emission reduction by the year 2030. LONGi hopes to collaborate with other partners to drive the global transition towards sustainable energy and realize the harmony between humanity and the environment together." says Talsiman Huo, General Manager of Brand Management DepartmentBrand Management Department, LONGi. The recent Intergovernmental Panel on Climate Change (IPCC) special report emphasized the urgent need to limit global warming to 1.5°C and achieve net-zero emissions by mid-century. As a global leader in renewable sector, LONGi, with its high-quality products and sustainable branding influence, has earned recognition and trust from numerous customers around the world. Looking ahead, LONGi will continue to focus on sustainable technology innovation, creating competitive products and solutions by R&D investment and finally achieving the goal of global energy transition. About LONGi Founded in 2000, LONGi is committed to being the world's leading solar technology company, focusing on customer-driven value creation for full scenario energy transformation. Under its mission of 'making the best of solar energy to build a green world', LONGi has dedicated itself to technology innovation and established five business sectors, covering mono silicon wafers cells and modules, commercial & industrial distributed solar solutions, green energy solutions and hydrogen equipment. The company has honed its capabilities to provide green energy and has more recently, also embraced green hydrogen products and solutions to support global zero carbon development. www.longi.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 2879 加入收藏 :
2025 年 2 月 14 日 (星期五) 農曆正月十七日
首 頁 我的收藏 搜 尋 新聞發佈